琥珀酰化
赖氨酸
癌症研究
免疫疗法
癌症
化学
组蛋白
免疫系统
药理学
表观遗传学
免疫原性
抄写(语言学)
癌症免疫疗法
生物化学
医学
癌细胞
转录因子
细胞凋亡
柠檬酸循环
乙酰化
靶向治疗
莱菔硫烷
生物
组蛋白H3
癌症治疗
作者
Xinliang Gu,Y Zhang,Y W Li,Xun� Li,Yuening Sun,Shuo Ma,Xinyue Qin,Yuejiao Huang,Xianjuan Shen,Ming Zheng,Quanhua Yi,Zhiyuan Tang,Shaoqing Ju
标识
DOI:10.1186/s13046-026-03758-8
摘要
Background Transfer RNA-derived small RNAs (tsRNAs) have been implicated in tumor progression and immune regulation in recent years. However, the specific role of tRNA halves (tiRNAs), a subclass of tsRNAs, in modulating immunotherapy response remains unexplored. Methods and results In this study, 5’-tiRNA Gly levels were examined in gastric cancer (GC) patients and found to be upregulated, especially in non-responders to anti-PD-1 therapy. Elevated 5’-tiRNA Gly levels were also associated with diminished oxoglutarate dehydrogenase-like (OGDHL) expression. Further exploration revealed that 5’-tiRNA Gly bound to DLST and promoted OGDHL destabilization, whereas targeted inhibition of 5’-tiRNA Gly restored OGDHL stability through succinylation at lysine 910, enhanced tricarboxylic acid (TCA) cycle activity, and reduced glutamine-derived metabolic reprogramming. Additionally, 5’-tiRNA Gly was found to decrease the activity of α-ketoglutarate dehydrogenase and inhibit succinylation of histone H3 at lysine 79 (H3K79suc), thereby downregulating PD-L1 transcription and reducing therapeutic responsiveness to PD-1 inhibitors. Conversely, restoration of this epigenetic modification upon 5’-tiRNA Gly inhibition facilitated PD-L1 transcription, thereby sensitizing tumors to anti-PD-1 therapy. Conclusion Our findings indicate that targeting 5’-tiRNA Gly may represent a promising strategy to enhance responsiveness to anti-PD-1 therapy in GC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI